Jun 30, 2022

Arcturus Therapeutics Q2 2022 Earnings Report

Total Revenue
$27.1M
Previous year: $2M
+1254.0%
EPS
-$0.82
Previous year: -$2.07
-60.4%
Gross Profit
$27.1M
Previous year: $2M
+1254.0%
Cash and Equivalents
$283M
Previous year: $434M
-34.6%
Free Cash Flow
-$36.4M
Previous year: -$33.3M
+9.3%
Total Assets
$337M
Previous year: $449M
-24.9%

Arcturus Therapeutics

Arcturus Therapeutics